195 related articles for article (PubMed ID: 36234761)
1. Effects of Chemical Structures Interacting with Amine Oxidases on Glucose, Lipid and Hydrogen Peroxide Handling by Human Adipocytes.
Carpéné C; Viana P; Iffiú-Soltesz Z; Tapolcsányi P; Földi AÁ; Mátyus P; Dunkel P
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234761
[TBL] [Abstract][Full Text] [Related]
2. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
3. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.
Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P
Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
Visentin V; Prévot D; Marti L; Carpéné C
Eur J Pharmacol; 2003 Apr; 466(3):235-43. PubMed ID: 12694806
[TBL] [Abstract][Full Text] [Related]
6. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
7. Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases.
Visentin V; Morin N; Fontana E; Prévot D; Boucher J; Castan I; Valet P; Grujic D; Carpéné C
J Pharmacol Exp Ther; 2001 Oct; 299(1):96-104. PubMed ID: 11561068
[TBL] [Abstract][Full Text] [Related]
8. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
9. Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.
Iglesias-Osma MC; Bour S; Garcia-Barrado MJ; Visentin V; Pastor MF; Testar X; Marti L; Enrique-Tarancon G; Valet P; Moratinos J; Carpéné C
Pharmacol Res; 2005 Dec; 52(6):475-84. PubMed ID: 16135411
[TBL] [Abstract][Full Text] [Related]
10. Dietary Phenolic Compounds Interfere with the Fate of Hydrogen Peroxide in Human Adipose Tissue but Do Not Directly Inhibit Primary Amine Oxidase Activity.
Carpéné C; Hasnaoui M; Balogh B; Matyus P; Fernández-Quintela A; Rodríguez V; Mercader J; Portillo MP
Oxid Med Cell Longev; 2016; 2016():2427618. PubMed ID: 26881018
[TBL] [Abstract][Full Text] [Related]
11. Multiple Direct Effects of the Dietary Protoalkaloid
Carpéné C; Viana P; Fontaine J; Laurell H; Grolleau JL
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956295
[TBL] [Abstract][Full Text] [Related]
12. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
13. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
[TBL] [Abstract][Full Text] [Related]
14. Histamine oxidation in mouse adipose tissue is controlled by the AOC3 gene-encoded amine oxidase.
Iffiú-Soltész Z; Wanecq E; Prévot D; Grès S; Carpéné C
Inflamm Res; 2010 Mar; 59 Suppl 2():S227-9. PubMed ID: 20012150
[TBL] [Abstract][Full Text] [Related]
15. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
16. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.
Fontana E; Boucher J; Marti L; Lizcano JM; Testar X; Zorzano A; Carpéné C
Biochem J; 2001 Jun; 356(Pt 3):769-77. PubMed ID: 11389684
[TBL] [Abstract][Full Text] [Related]
17. Tyramine stimulates glucose uptake in insulin-sensitive tissues in vitro and in vivo via its oxidation by amine oxidases.
Morin N; Visentin V; Calise D; Marti L; Zorzano A; Testar X; Valet P; Fischer Y; Carpéné C
J Pharmacol Exp Ther; 2002 Dec; 303(3):1238-47. PubMed ID: 12438548
[TBL] [Abstract][Full Text] [Related]
18. High doses of tyramine stimulate glucose transport in human fat cells.
Carpéné C; Les F; Mercader-Barceló J; Boulet N; Briot A; Grolleau JL
J Physiol Biochem; 2022 May; 78(2):543-556. PubMed ID: 35066863
[TBL] [Abstract][Full Text] [Related]
19. The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.
Carpéné C; Grès S; Rascalou S
J Neural Transm (Vienna); 2013 Jun; 120(6):997-1003. PubMed ID: 23242743
[TBL] [Abstract][Full Text] [Related]
20. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.
Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C
Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
